Published in Mutat Res on August 11, 1999
Assessment of 1,3-butadiene exposure in polymer production workers using HPRT mutations in lymphocytes as a biomarker. Environ Health Perspect (2001) 0.88
Column switching HPLC-ESI(+)-MS/MS methods for quantitative analysis of exocyclic dA adducts in the DNA of laboratory animals exposed to 1,3-butadiene. Chem Res Toxicol (2010) 0.87
Alkyltransferase-mediated toxicity of 1,3-butadiene diepoxide. Chem Res Toxicol (2008) 0.87
NanoHPLC-nanoESI(+)-MS/MS quantitation of bis-N7-guanine DNA-DNA cross-links in tissues of B6C3F1 mice exposed to subppm levels of 1,3-butadiene. Anal Chem (2012) 0.82
Variability in human sensitivity to 1,3-butadiene: influence of polymorphisms in the 5'-flanking region of the microsomal epoxide hydrolase gene (EPHX1). Toxicol Sci (2005) 0.77
An expectation maximization (EM) algorithm for the identification and characterization of common sites in unaligned biopolymer sequences. Proteins (1990) 4.42
The prevalence and intra-oral distribution of Candida albicans in man. Arch Oral Biol (1980) 2.54
Oral candidal populations in health and disease. Br Dent J (1979) 2.48
Highly sensitive apurinic/apyrimidinic site assay can detect spontaneous and chemically induced depurination under physiological conditions. Cancer Res (1998) 2.12
Oral submucous fibrosis. A review. Aust Dent J (1996) 2.06
Defect of cell-mediated immunity in patients with iron-deficiency anaemia. Lancet (1972) 2.01
Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J (1996) 1.91
Diesel exhaust is a pulmonary carcinogen in rats exposed chronically by inhalation. Fundam Appl Toxicol (1987) 1.65
Comparative pulmonary toxicities and carcinogenicities of chronically inhaled diesel exhaust and carbon black in F344 rats. Fundam Appl Toxicol (1995) 1.60
Visual hallucinations associated with fluoxetine and sertraline. J Clin Psychopharmacol (1998) 1.58
Outer membrane protein-specific monoclonal antibodies protect SCID mice from fatal infection by the obligate intracellular bacterial pathogen Ehrlichia chaffeensis. J Immunol (2001) 1.56
Candidal infections and populations of Candida albicans in mouths of diabetics. J Clin Pathol (1981) 1.51
The cytoplasmic domain of L-selectin interacts with cytoskeletal proteins via alpha-actinin: receptor positioning in microvilli does not require interaction with alpha-actinin. J Cell Biol (1995) 1.44
Screening children exposed to lead: an assessment of the capillary blood lead fingerstick test. Clin Chem (1997) 1.39
Effect of dose on the absorption and excretion of [14C]benzene administered orally or by inhalation in rats and mice. Toxicol Appl Pharmacol (1987) 1.34
Effects of D2O on the association-dissociation equilibrium in subunit proteins. J Biol Chem (1970) 1.34
Habituation of activity in an open field: A survey of inbred strains and F1 hybrids. Behav Genet (2000) 1.32
Denture stomatitis: a review. J Oral Rehabil (1987) 1.30
Differences in the metabolism and disposition of inhaled [3H]benzene by F344/N rats and B6C3F1 mice. Toxicol Appl Pharmacol (1988) 1.27
Glycine enhances NMDA-receptor mediated synaptic potentials in neocortical slices. Nature (1989) 1.25
Identification and characterization of the glucose transporter of the blood-brain barrier by cytochalasin B binding and immunological reactivity. Proc Natl Acad Sci U S A (1984) 1.25
Establishing a normal range for mouth opening: its use in screening for oral submucous fibrosis. Br J Oral Maxillofac Surg (1997) 1.24
Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario. CMAJ (1996) 1.22
Tobacco smoking and denture wearing in oral candidal leukoplakia. Br Dent J (1983) 1.18
Anterolateral rotatory instability of the knee joint. An early analysis of the Ellison procedure. J Bone Joint Surg Am (1978) 1.14
Calcifying epithelial odontogenic (Pindborg) tumor with malignant transformation and metastatic spread. Head Neck (2001) 1.13
A case of aggressive multiple metachronous central giant cell granulomas of the jaws: differential diagnosis and management options. Int J Oral Maxillofac Surg (2005) 1.13
Vinyl chloride-induced DNA adducts. II: Formation and persistence of 7-(2'-oxoethyl)guanine and N2,3-ethenoguanine in rat tissue DNA. Carcinogenesis (1990) 1.11
Effect of exposure concentration, exposure rate, and route of administration on metabolism of benzene by F344 rats and B6C3F1 mice. Toxicol Appl Pharmacol (1989) 1.09
Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK. Heart (2009) 1.09
A physiological model for simulation of benzene metabolism by rats and mice. Toxicol Appl Pharmacol (1989) 1.08
Minichromosomes derived from the B chromosome of maize. Cytogenet Genome Res (2005) 1.07
Muconic acid determinations in urine as a biological exposure index for workers occupationally exposed to benzene. Am Ind Hyg Assoc J (1991) 1.07
Sicca syndrome associated with idiopathic haemochromatosis. Br Med J (1979) 1.07
Factors contributing to chromosome damage in lymphocytes of cigarette smokers. Mutat Res (1991) 1.06
Trihalomethanes in drinking water and human colorectal cancer. J Natl Cancer Inst (1984) 1.06
A high pressure liquid chromatographic method for the separation and quantitation of water-soluble radiolabeled benzene metabolites. Anal Biochem (1988) 1.06
Evaluation of blood lead proficiency testing: comparison of open and blind paradigms. Clin Chem (2001) 1.06
New approaches for the evaluation of pulmonary toxicity: bronchoalveolar lavage fluid analysis. Fundam Appl Toxicol (1985) 1.06
Use of bronchoalveolar lavage to detect lung damage. Environ Health Perspect (1984) 1.06
S-phenylcysteine formation in hemoglobin as a biological exposure index to benzene. Arch Toxicol (1992) 1.05
Toxicity of gallium oxide particles following a 4-week inhalation exposure. J Appl Toxicol (1988) 1.05
Early damage indicators in the the lung I. Lactate dehydrogenase activity in the airways. Toxicol Appl Pharmacol (1978) 1.05
Species differences in the disposition of inhaled butadiene. Toxicol Appl Pharmacol (1986) 1.04
Orofacial granulomatosis in childhood. Br Dent J (1987) 1.04
Inhibition of Escherichia coli glutamine synthetase by alpha- and gamma-substituted phosphinothricins. Biochemistry (1990) 1.03
Substrate variability as a factor in enzyme inhibitor design: inhibition of ovine brain glutamine synthetase by alpha- and gamma-substituted phosphinothricins. Biochemistry (1989) 1.03
Alterations in particle accumulation and clearance in lungs of rats chronically exposed to diesel exhaust. Fundam Appl Toxicol (1987) 1.01
Mutational spectrum at the Hprt locus in splenic T cells of B6C3F1 mice exposed to N-ethyl-N-nitrosourea. Proc Natl Acad Sci U S A (1992) 1.00
The release of residual monomeric methyl methacrylate from acrylic appliances in the human mouth: an assay for monomer in saliva. J Dent Res (1988) 1.00
Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene. Chem Res Toxicol (1999) 0.99
A rapid, semi-automated procedure for the evaluation of leukocyte locomotion in the micropore filter assay. J Immunol Methods (1979) 0.99
Biomarkers for assessing occupational exposures to 1,3-butadiene. Chem Biol Interact (2001) 0.98
Prevalence and intraoral distribution of Candida albicans in Sjögren's syndrome. J Clin Pathol (1980) 0.98
The effect of secretory immunoglobulin A on the in-vitro adherence of the yeast Candida albicans to human oral epithelial cells. Arch Oral Biol (1982) 0.98
Identification of subpopulations of lymphocytes and macrophages in the infiltrate of lichen planus lesions of skin and oral mucosa. Br J Dermatol (1976) 0.97
Fluoroimmunoassay studies with solubilized antigens from Borrelia burgdorferi. J Clin Microbiol (1989) 0.96
Rotavirus-associated diarrhea in a commercial rabbitry. Lab Anim Sci (1986) 0.96
Effects of dimethyl sulfoxide on subunit proteins. Ann N Y Acad Sci (1975) 0.96
Quantitative analysis of 1,3-butadiene-induced DNA adducts in vivo and in vitro using liquid chromatography electrospray ionization tandem mass spectrometry. J Mass Spectrom (1998) 0.96
Early damage indicators in the lung. III. Biochemical and cytological response of the lung to inhaled metals salts. Toxicol Appl Pharmacol (1979) 0.95
BAL fluid LDH activity and LDH isoenzyme pattern in lipoid pneumonia caused by an intravenous injection of lamp oil. Eur Respir J (1996) 0.95
A reverse isotope dilution method for determining benzene and metabolites in tissues. J Anal Toxicol (1988) 0.95
The fate of isoprene inhaled by rats: comparison to butadiene. Toxicol Appl Pharmacol (1987) 0.94
An improved medium for isolation of Streptococcus mutans. J Med Microbiol (1986) 0.93
Early damage indicators in the lungs. IV. Biochemical and cytologic response of the lung to lavage with metal salts. Toxicol Appl Pharmacol (1979) 0.93
Inflammatory cells extracted from chronically inflamed gingiva. J Periodontal Res (1979) 0.93
Zidovudine-didanosine coexposure potentiates DNA incorporation of zidovudine and mutagenesis in human cells. Proc Natl Acad Sci U S A (2000) 0.93
Early damage indicators in the lung. V. Biochemical and cytological response to NO2 inhalation. Toxicol Appl Pharmacol (1981) 0.93
Occult knee ligament injuries associated with femoral shaft fractures. Am J Sports Med (1980) 0.92
Estimating serum polychlorinated biphenyl levels in highly exposed workers: an empirical model. J Toxicol Environ Health (1991) 0.92
CYP1B1 expression in human lung. Drug Metab Dispos (2001) 0.92
Species differences in urinary butadiene metabolites: comparisons of metabolite ratios between mice, rats, and humans. Toxicol Appl Pharmacol (1994) 0.92
Diesel exhaust is not a pulmonary carcinogen in CD-1 mice exposed under conditions carcinogenic to F344 rats. Fundam Appl Toxicol (1996) 0.92
Using DNA and hemoglobin adducts to improve the risk assessment of butadiene. Chem Biol Interact (2001) 0.92
Species differences in the distribution of inhaled butadiene in tissues. Am Ind Hyg Assoc J (1987) 0.92
Toxicokinetics of inhaled 1,3-butadiene in monkeys: comparison to toxicokinetics in rats and mice. Toxicol Appl Pharmacol (1991) 0.92
Primary orbital Ewing sarcoma in a middle-aged man. Ophthal Plast Reconstr Surg (2005) 0.92
Effects of 0.12 and 0.80 ppm ozone on rat nasal and nasopharyngeal epithelial mucosubstances: quantitative histochemistry. Toxicol Pathol (1989) 0.91
The molecular epidemiology of lung cancer. Crit Rev Toxicol (1997) 0.91
Haemolysis following mitral valve repair. J Cardiovasc Surg (Torino) (1992) 0.91
Increased production of tumour necrosis factor by peripheral blood leukocytes in patients with recurrent oral aphthous ulceration. J Oral Pathol Med (1992) 0.91
Epithelial p53 gene expression and mutational analysis, combined with growth fraction assessment, in oral lichen planus. J Oral Pathol Med (1998) 0.90
Species differences in urinary butadiene metabolites; identification of 1,2-dihydroxy-4-(N-acetylcysteinyl)butane, a novel metabolite of butadiene. Carcinogenesis (1992) 0.90
A single five minute period of rapid atrial pacing fails to limit infarct size in the in situ rabbit heart. Cardiovasc Res (1993) 0.90
Prolonged incubation period of AIDS in intravenous drug abusers: epidemiological evidence in prison inmates. J Infect Dis (1984) 0.90
Nystatin in denture liners--an alternative treatment of denture stomatitis. Br Dent J (1973) 0.89
Biochemical responses of rat and mouse lung to inhaled nickel compounds. Toxicology (1989) 0.88
Intraperitoneal administration of coumarin causes tissue-selective depletion of cytochromes P450 and cytotoxicity in the olfactory mucosa. Toxicol Appl Pharmacol (1997) 0.88
Response of rat alveolar macrophages to ozone: quantitative assessment of population size, morphology, and proliferation following acute exposure. Exp Lung Res (1989) 0.88
Assessment of butadiene exposure in synthetic rubber manufacturing workers in Texas using frequencies of hprt mutant lymphocytes as a biomarker. Chem Biol Interact (2001) 0.88
Surgical ciliated (postoperative maxillary) cysts following mid-face osteotomies. Br J Oral Maxillofac Surg (1990) 0.87
A model for the formation and removal of hemoglobin adducts. Cancer Epidemiol Biomarkers Prev (1993) 0.87
Proliferative responses of rat nasal epithelia to ozone. Toxicol Appl Pharmacol (1990) 0.87
Fungal Planet description sheets: 128-153. Persoonia (2012) 0.87
Tongue cancer: do patients younger than 40 do worse? Aust Dent J (2003) 0.87